Immuno-Biological Laboratories Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immuno-Biological Laboratories Company Limited with three other
drug stores in Asia:
FCW Holdings Berhad
sales of 26.57 million Malaysian Ringgits [US$6.00 million]
of which 100%
Muller and Phipps (Ceylon) Plc
of Sri Lanka
(903.25 million Sri Lanka Rupees [US$5.95 million]
Ibl Healthcare Limited
based in Pakistan
(1.16 billion Pakistan Rupees [US$11.04 million]
During the year ended March of 2016, sales at
Immuno-Biological Laboratories Company Limited were ¥717.66 million (US$6.44 million).
decrease of 1.6%
versus 2015, when the company's sales were ¥729.03 million.
Contributing to the drop in overall sales was the 37.4% decline
in Cosmetics Related Business, from ¥25.21 million to ¥15.79 million.
There were also decreases in sales in
Examine Business (down 0.1% to ¥109.74 million)
Recombinant Silkworm (down 25.1% to ¥67.41 million)
However, these declines were partially offset by the increase in sales of
Diagnosis and Reagent (up 4.1% to ¥524.72 million)